Aurinia Pharmaceuticals to Present at Investor Conference
TipRanksApr 16 11:38 ET
Express News | Update: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
Moomoo 24/7Apr 16 10:48 ET
Express News | Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Moomoo 24/7Apr 15 06:00 ET
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company) today announced that it will attend the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place at the Metro Toronto Convention Centre
BusinesswireApr 9 06:00 ET
When Will Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Breakeven?
Yahoo FinanceApr 7 10:47 ET
When Can We Expect A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)?
We feel now is a pretty good time to analyse Aurinia Pharmaceuticals Inc.'s (NASDAQ:AUPH) business as it appears the company may be on the cusp of a considerable accomplishment. Aurinia Pharmaceutic
Simply Wall StApr 2 08:05 ET
11 Oversold Biotech Stocks To Buy Right Now
Yahoo FinanceMar 17 17:20 ET
Aurinia Pharmaceuticals (NASDAQ:AUPH Shareholders Incur Further Losses as Stock Declines 6.1% This Week, Taking Three-year Losses to 61%
Investing in stocks inevitably means buying into some companies that perform poorly. But long term Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shareholders have had a particularly rough ride in the la
Simply Wall StMar 9 07:33 ET
We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn
Yahoo FinanceMar 8 13:52 ET
Aurinia Pharmaceuticals Insider Sold Shares Worth $323,372, According to a Recent SEC Filing
Stephen P. Robertson, Executive Vice President, General Counsel, on March 06, 2024, sold 57,745 shares in Aurinia Pharmaceuticals (AUPH) for $323,372. Following the Form 4 filing with the SEC, Roberts
MT NewswiresMar 7 16:46 ET
Express News | HC Wainwright & Co. Reiterates Buy on Aurinia Pharmaceuticals, Maintains $13 Price Target
Moomoo 24/7Mar 1 14:09 ET
Aurinia Pharmaceuticals: Strong Buy Rating Amidst Share Repurchase and Promising LUPKYNIS Prospects
TipRanksMar 1 11:55 ET
Aurinia Pharmaceuticals(AUPH.US) Officer Sells US$30,073 in Common Stocks
$Aurinia Pharmaceuticals(AUPH.US)$ Officer Knappertz Volker sold 4,930 shares of Common Stocks on Feb 27, 2024 at an average price of $6.1 for a total value of $30,073.Source: Announcement What is sta
moomoo NewsFeb 29 16:54 ET
Aurinia Pharmaceuticals Announces Executive R&D Leadership Change
TipRanksFeb 29 16:23 ET
Aurinia Pharmaceuticals Launches Share Buyback Plan
TipRanksFeb 29 09:18 ET
Aurinia Pharmaceuticals May Purchase Up to 15 % of Issued and Outstanding Shrs in Any 12-Mo Period for Up to 36 Mos >AUPH
Aurinia Pharmaceuticals May Purchase Up to 15 % of Issued and Outstanding Shrs in Any 12-Mo Period for Up to 36 Mos >AUPH
Dow JonesFeb 29 08:37 ET
Aurinia Receives Exemptive Relief From Canadian Securities Regulators For Share Repurchase Program >AUPH
Aurinia Receives Exemptive Relief From Canadian Securities Regulators For Share Repurchase Program >AUPH
Dow JonesFeb 29 08:30 ET
Aurinia Receives Exemptive Relief From Canadian Securities Regulators for Share Repurchase Program
Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program February 29, 2024 • 8:30 am EST Download as PDF ROCKVI
Aurinia PharmaceuticalsFeb 29 00:00 ET
Aurinia to Participate in Upcoming Investor Healthcare Conferences
Aurinia to Participate in Upcoming Investor Healthcare Conferences February 27, 2024 • 8:30 am EST Download as PDF ROCKVILLE, Md. & EDMONTON, Alberta--(B
Aurinia PharmaceuticalsFeb 27 00:00 ET
Aurinia Pharmaceuticals Price Target Cut to $10.00/Share From $12.00 by Cantor Fitzgerald
Aurinia Pharmaceuticals Price Target Cut to $10.00/Share From $12.00 by Cantor Fitzgerald
Dow JonesFeb 23 12:21 ET
No Data
No Data